v3.25.2
EQUITY TRANSACTIONS
 3 Months Ended
Jul. 31, 2025
Equity [Abstract]  
EQUITY TRANSACTIONS

NOTE E – EQUITY TRANSACTIONS

 

Preferred Stock

 

The Company is authorized to issue 10,000,000 shares of preferred stock with $0.001 par value per share, of which 35,850 shares have been designated as Series A convertible preferred stock with a $100 stated value per share; 1,000 shares have been designated as Series B Preferred Stock with a $10,000 per share liquidation value; 4,200,000 shares have been designated as Series C Preferred Stock with a $1.00 per share liquidation value, and 2,000,000 shares have been designated as Series D Preferred Stock with a $1 per share liquidation value. During the three months ended July 31, 2025, and 2024, the Company did not issue any preferred stock.

 

Common Stock

 

The Company is authorized to issue 750,000,000 shares of common stock, $0.001 par value. The Company had 41,502,464 and 40,133,669 shares of common stock issued and outstanding as of July 31, 2025, and April 30, 2025, respectively. The Company had 34,201,299 and 33,612,875 shares of common classified as to be issued at July 31, 2025, and April 30, 2025, respectively.

 

During the three months ended July 31, 2025, the Company

 

  ●

Issued 450,000 shares valued at $54,435 for consulting services

  ●

Issued 136,809 shares of common stock valued at $19,985 upon the settlement of liability

  ● Issued 781,986 shares and 538,424 shares to be issued valued at $95,000 to accredited investors related to equity investments which includes 660,205 warrants at fair value of $25,869
  ●

50,000 shares of common stock to be issued valued at $4,000 to accredited investors relating to promissory notes

 

During the three months ended July 31, 2024, the Company:

 

  ● Issued 2,379,923 shares and 1,405,340 shares to be issued valued at $335,000 to accredited investors related to equity investments.
  ● Issued 200,000 shares valued at $23,000 for consulting services.
  ● 200,000 shares of common stock to be issued as an incentive to noteholder valued at $18,640.
  ● Issued 750,000 shares of common stock valued at $75,000 upon the conversion of convertible notes
  ● Issued 1,891,633 warrants valued at $72,558 as part of conversion of convertible notes

 

 

Preferred Stock

 

The Company is authorized to issue 10,000,000 shares of preferred stock with $0.001 par value per share, of which 35,850 shares have been designated as Series A convertible preferred stock with a $100 stated value per share; 1,000 shares have been designated as Series B Preferred Stock with a $10,000 per share liquidation value; 4,200,000 shares have been designated as Series C Preferred Stock with a $1 per share liquidation value, and 2,000,000 shares have been designated as Series D Preferred Stock with a $1 per share liquidation value.

 

During the three months ended July 31, 2025, and 2024, the Company did not issue any preferred stock.

 

As of July 31, 2025, and April 30, 2025, the Company had:

 

   July 31,   April 30, 
Preferred stock outstanding shares  2025   2025 
Series A   125    125 
Series B   -    - 
Series C   1,953,157    1,953,157 
Series D   773,548    773,548